Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021

SELL
$232.72 - $256.47 $245 Million - $270 Million
-1,051,113 Closed
0 $0
Q2 2021

Aug 09, 2021

SELL
$232.65 - $254.58 $161 Million - $176 Million
-691,383 Reduced 39.68%
1,051,113 $256 Million
Q1 2021

May 14, 2021

SELL
$232.09 - $256.88 $12.7 Million - $14.1 Million
-54,784 Reduced 3.05%
1,742,496 $424 Million
Q4 2020

Feb 11, 2021

SELL
$221.92 - $245.94 $28.8 Million - $31.9 Million
-129,587 Reduced 6.73%
1,797,280 $450 Million
Q3 2020

Nov 10, 2020

SELL
$215.77 - $276.76 $51.4 Million - $65.9 Million
-238,133 Reduced 11.0%
1,926,867 $448 Million
Q2 2020

Aug 13, 2020

SELL
$219.9 - $263.41 $119 Million - $143 Million
-541,348 Reduced 20.0%
2,165,000 $518 Million
Q1 2020

May 14, 2020

BUY
$195.69 - $279.01 $55.1 Million - $78.5 Million
281,348 Added 11.6%
2,706,348 $622 Million
Q4 2019

Feb 12, 2020

BUY
$236.45 - $266.82 $53.2 Million - $60 Million
225,000 Added 10.23%
2,425,000 $660 Million
Q3 2019

Nov 05, 2019

SELL
$230.58 - $256.08 $4.61 Million - $5.12 Million
-20,000 Reduced 0.9%
2,200,000 $557 Million
Q2 2019

Aug 07, 2019

BUY
$217.4 - $246.08 $37 Million - $41.8 Million
170,000 Added 8.29%
2,220,000 $559 Million
Q4 2018

Feb 12, 2019

BUY
$204.73 - $257.93 $52.2 Million - $65.8 Million
255,000 Added 14.21%
2,050,000 $462 Million
Q2 2018

Aug 07, 2018

BUY
$208.1 - $233.85 $41.6 Million - $46.8 Million
200,000 Added 12.54%
1,795,000 $430 Million
Q1 2018

May 09, 2018

SELL
$205.46 - $240.27 $22.6 Million - $26.4 Million
-110,000 Reduced 6.45%
1,595,000 $346 Million
Q4 2017

Feb 08, 2018

SELL
$189.0 - $222.64 $11.3 Million - $13.4 Million
-60,000 Reduced 3.4%
1,705,000 $365 Million
Q3 2017

Nov 08, 2017

BUY
$186.89 - $198.9 $330 Million - $351 Million
1,765,000
1,765,000 $346 Million

Others Institutions Holding BDX

About BECTON DICKINSON & CO


  • Ticker BDX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 285,195,008
  • Market Cap $65.1B
  • Description
  • Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...
More about BDX
Track This Portfolio

Track Findlay Park Partners LLP Portfolio

Follow Findlay Park Partners LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Findlay Park Partners LLP, based on Form 13F filings with the SEC.

News

Stay updated on Findlay Park Partners LLP with notifications on news.